Literature DB >> 18761338

The role of the EGF family of ligands and receptors in renal development, physiology and pathophysiology.

Fenghua Zeng1, Amar B Singh, Raymond C Harris.   

Abstract

Mammalian kidney expresses all of the members of the ErbB family of receptors and their respective ligands. Studies support a role for ErbB family receptor activation in kidney development and differentiation. Under physiologic conditions, EGFR activation appears to play an important role in the regulation of renal hemodynamics and electrolyte handling by the kidney, while in different pathophysiologic states, EGFR activation may mediate either beneficial or detrimental effects to the kidney. This article provides an overview of the expression profile of the ErbB family of ligands and receptors in the mammalian kidney and summarizes known physiological and pathophysiological roles of EGFR activation in the organ.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18761338      PMCID: PMC2654782          DOI: 10.1016/j.yexcr.2008.08.005

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  129 in total

1.  Emerging roles of TACE as a key protease in ErbB ligand shedding.

Authors:  Peter J Dempsey; Kyle Garton; Elaine W Raines
Journal:  Mol Interv       Date:  2002-06

2.  Evidence for glomerular actions of epidermal growth factor in the rat.

Authors:  R C Harris; R L Hoover; H R Jacobson; K F Badr
Journal:  J Clin Invest       Date:  1988-09       Impact factor: 14.808

3.  Epidermal growth factor receptor activation differentially regulates claudin expression and enhances transepithelial resistance in Madin-Darby canine kidney cells.

Authors:  Amar B Singh; Raymond C Harris
Journal:  J Biol Chem       Date:  2003-10-30       Impact factor: 5.157

4.  EGF-related growth factors in the pathogenesis of murine ARPKD.

Authors:  Katherine MacRae Dell; Raghad Nemo; William E Sweeney; Ellis D Avner
Journal:  Kidney Int       Date:  2004-06       Impact factor: 10.612

5.  Phase II trial of ZD1839 (IRESSA) in patients with advanced renal cell carcinoma.

Authors:  Beverly Drucker; Jennifer Bacik; Michelle Ginsberg; Stephanie Marion; Paul Russo; Madhu Mazumdar; Robert Motzer
Journal:  Invest New Drugs       Date:  2003-08       Impact factor: 3.850

6.  Hypoxia inducible factor activates the transforming growth factor-alpha/epidermal growth factor receptor growth stimulatory pathway in VHL(-/-) renal cell carcinoma cells.

Authors:  Lakshman Gunaratnam; Melissa Morley; Aleksandra Franovic; Natalie de Paulsen; Karim Mekhail; Doris A E Parolin; Eijiro Nakamura; Ian A J Lorimer; Stephen Lee
Journal:  J Biol Chem       Date:  2003-08-27       Impact factor: 5.157

7.  Importance of functional EGF receptors in recovery from acute nephrotoxic injury.

Authors:  Zoufei Wang; Jian-Kang Chen; Su-Wan Wang; Gilbert Moeckel; Raymond C Harris
Journal:  J Am Soc Nephrol       Date:  2003-12       Impact factor: 10.121

8.  Spatiotemporal regulation of morphogenetic molecules during in vitro branching of the isolated ureteric bud: toward a model of branching through budding in the developing kidney.

Authors:  Tobias N Meyer; Catherine Schwesinger; Kevin T Bush; Robert O Stuart; David W Rose; Mita M Shah; Duke A Vaughn; Dylan L Steer; Sanjay K Nigam
Journal:  Dev Biol       Date:  2004-11-01       Impact factor: 3.582

9.  Evidence for epidermal growth factor receptor as negative-feedback control in aldosterone-induced Na+ reabsorption.

Authors:  Claudia Grossmann; Ruth Freudinger; Sigrid Mildenberger; Alexander W Krug; Michael Gekle
Journal:  Am J Physiol Renal Physiol       Date:  2004-01-28

10.  Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands.

Authors:  Umut Sahin; Gisela Weskamp; Kristine Kelly; Hong-Ming Zhou; Shigeki Higashiyama; Jacques Peschon; Dieter Hartmann; Paul Saftig; Carl P Blobel
Journal:  J Cell Biol       Date:  2004-03-01       Impact factor: 10.539

View more
  72 in total

1.  Lipocalin 2 is essential for chronic kidney disease progression in mice and humans.

Authors:  Amandine Viau; Khalil El Karoui; Denise Laouari; Martine Burtin; Clément Nguyen; Kiyoshi Mori; Evangéline Pillebout; Thorsten Berger; Tak Wah Mak; Bertrand Knebelmann; Gérard Friedlander; Jonathan Barasch; Fabiola Terzi
Journal:  J Clin Invest       Date:  2010-11       Impact factor: 14.808

2.  A look at transactivation of the EGF receptor by angiotensin II.

Authors:  Hirokazu Okada
Journal:  J Am Soc Nephrol       Date:  2012-01-12       Impact factor: 10.121

Review 3.  Epidermal growth factor receptor mediates injury in rapidly progressive glomerular disease.

Authors:  Sabine Brandt; Peter R Mertens
Journal:  Int Urol Nephrol       Date:  2012-03-24       Impact factor: 2.370

4.  TGF-alpha mediates genetic susceptibility to chronic kidney disease.

Authors:  Denise Laouari; Martine Burtin; Aurélie Phelep; Carla Martino; Evangeline Pillebout; Xavier Montagutelli; Gérard Friedlander; Fabiola Terzi
Journal:  J Am Soc Nephrol       Date:  2010-12-23       Impact factor: 10.121

Review 5.  Signal transduction in podocytes--spotlight on receptor tyrosine kinases.

Authors:  Jochen Reiser; Sanja Sever; Christian Faul
Journal:  Nat Rev Nephrol       Date:  2014-01-07       Impact factor: 28.314

Review 6.  TGF-β: the master regulator of fibrosis.

Authors:  Xiao-Ming Meng; David J Nikolic-Paterson; Hui Yao Lan
Journal:  Nat Rev Nephrol       Date:  2016-04-25       Impact factor: 28.314

7.  TGFβ acts through PDGFRβ to activate mTORC1 via the Akt/PRAS40 axis and causes glomerular mesangial cell hypertrophy and matrix protein expression.

Authors:  Soumya Maity; Falguni Das; Balakuntalam S Kasinath; Nandini Ghosh-Choudhury; Goutam Ghosh Choudhury
Journal:  J Biol Chem       Date:  2020-07-30       Impact factor: 5.157

8.  ErbB4 deletion accelerates renal fibrosis following renal injury.

Authors:  Fenghua Zeng; Tomoki Miyazawa; Lance A Kloepfer; Raymond C Harris
Journal:  Am J Physiol Renal Physiol       Date:  2017-07-19

9.  EGFR activity is required for renal tubular cell dedifferentiation and proliferation in a murine model of folic acid-induced acute kidney injury.

Authors:  Song He; Na Liu; George Bayliss; Shougang Zhuang
Journal:  Am J Physiol Renal Physiol       Date:  2012-12-19

Review 10.  Chronic kidney disease following acute kidney injury-risk and outcomes.

Authors:  Kelvin C W Leung; Marcello Tonelli; Matthew T James
Journal:  Nat Rev Nephrol       Date:  2012-12-18       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.